| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Dennis Phillip Andrew is a Chief Medical Officer at NovaBridge Biosciences. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $280K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | NBP Novabridge Biosciences | Chief Medical Officer | Sale+OE | 8,494 | $0.66 | $5,606.04 | -5.1% |